Yehia I Mohamed
5PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 11, 2024
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma.Shadi Chamseddine, Michael LaPelusa, Lianchun Xiao
|Sep 06, 2022
The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab.Muhammad O Awiwi, Khaled M Elsayes, Yehia I Mohamed
|Oct 01, 2021
Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma.Betul Gok Yavuz, Elshad Hasanov, Sunyoung S Lee
|Sep 16, 2021
A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by 90Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma.Ahmed Omar Kaseb, S Cheenu Kappadath, Sunyoung S Lee
|Apr 03, 2021
The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection.Ahmed O Kaseb, Yehia I Mohamed, Alexandre E Malek
Pageof 1
Frequent Collaborators
2 joint publications
Khaled M Elsayes
2 joint publications
James C Yao
1 joint publications
Ahmed O Kaseb
1 joint publications
Alexandre E Malek
1 joint publications
Omar A Kaseb
1 joint publications
Safa A Kaseb
1 joint publications
Mohamed E Abdelsalam
1 joint publications
Betul Gok Yavuz
1 joint publications
Eugene J Koay
1 joint publications
Muhammad O Awiwi
